IDYA Company Profile and Key Details
IDEAYA Biosciences, Inc.
IDYA Stock Price Chart
Stock Price Today
IDEAYA Biosciences, Inc. (IDYA) stock declined over -0.04%, trading at $23.14 on NASDAQ, down from the previous close of $23.15. The stock opened at $23.15, fluctuating between $23.04 and $23.72 in the recent session.
Stock Snapshot
Stock Price History Chart
Contact Details
About Company
IDEAYA Biosciences, Inc., a synthetic lethality-focused precision medicine oncology company, focuses on the discovery and development of targeted therapeutics for patient populations selected using molecular diagnostics. The company's lead product candidates include IDE397, a methionine adenosyltransferase 2a inhibitor that is in Phase I clinical trial for patients with solid tumors having methylthioadenosine phosphorylase deletions; and IDE196, a protein kinase C inhibitor that is in Phase I/II clinical trial for genetically defined cancers having GNAQ or GNA11 gene mutations. Its preclinical pipeline includes various synthetic lethality programs targeting PARG inhibitor in tumors for patients having tumors with a defined biomarker based on genetic mutations and/or molecular signatures; Pol Theta inhibitors in tumors with BRCA or other homologous recombination deficiency mutations; and WRN inhibitors in tumors with high microsatellite instability. The company has a research collaboration agreement with Cancer Research UK and the University of Manchester to develop small molecule inhibitors of Poly (ADP-ribose) glycohydrolase; and a clinical trial collaboration and supply agreement with Pfizer Inc. for Phase I/II study in metastatic uveal melanoma, skin melanoma, and other solid tumors, as well as a strategic partnership with GlaxoSmithKline plc. IDEAYA Biosciences, Inc. was incorporated in 2015 and is headquartered in South San Francisco, California.
Company Information
| Employees | 124 |
| Beta | 0.86 |
| Sales or Revenue | $23.39M |
| 5Y Sales Change% | 0% |
| Fiscal Year Ends | December |
| Sector | Healthcare |
| Industry | Biotechnology |
Frequently Asked Questions
IDEAYA Biosciences, Inc. (NASDAQ: IDYA) stock price is $23.14 in the last trading session. During the trading session, IDYA stock reached the peak price of $23.72 while $23.04 was the lowest point it dropped to. The percentage change in IDYA stock occurred in the recent session was -0.04% while the dollar amount for the price change in IDYA stock was -$0.01.
The NASDAQ listed IDYA is part of Biotechnology industry that operates in the broader Healthcare sector. IDEAYA Biosciences, Inc. designs, manufactures, and markets smartphones, personal computers, tablets, wearables, and accessories worldwide.
Mr. Paul A. Stone J.D.
Chief Financial Officer & Principal Accounting Officer
Mr. Mick O'Quigley
Senior Vice President of Devel. Operations
Mr. Andres Ruiz Briseno CPA
Vice President and Head of Bus. Operations & IR
Dr. Michael A. White Ph.D.
Senior Vice President & Chief Scientific Officer
Dr. Paul A. Barsanti Ph.D.
Chief Technology Officer
Dr. Darrin M. Beaupre M.D., Ph.D.
Chief Medical Officer
Mr. Jason S. Throne Esq., J.D.
Chief Legal Officer & Company Sec.
Mr. Paul A. Stone
Senior Vice President, Chief Financial Officer & Principal Accounting Officer
Mr. Jason S. Throne J.D., Esq.
Senior Vice President, Gen. Counsel & Company Sec.
Mr. Yujiro S. Hata
Co-Founder, Chief Executive Officer, Pres & Director
Dr. Jeffrey Hager Ph.D.
Co-Founder & Member of the Scientific Advisory Board
Dr. Matthew Maurer M.D.
Vice President and Head of Medical Affairs & Clinical Oncology
IDYA's closing price is 4.71% higher than its 52-week low of $22.10 where as its distance from 52-week high of $47.74 is -51.52%.
Number of IDYA employees currently stands at 124.
Official Website of IDYA is: https://www.ideayabio.com
IDYA could be contacted at phone 650 443 6209 and can also be accessed through its website. IDYA operates from 7000 Shoreline Court, South San Francisco, CA 94080, United States.
IDYA stock volume for the day was 579.53K shares. The average number of IDYA shares traded daily for last 3 months was 901.98K.
The market value of IDYA currently stands at $2.00B with its latest stock price at $23.14 and 86.43M of its shares outstanding.
Stocks Telegraph provides information and tools designed to assist investors and Wall Street players. A major goal is to offer financiers comprehensive information that will help them gain insight into investing.
© 2025 Stocks Telegraph All rights reserved.
Most stock quote data provided by financialmodelingprep.com